Impact of LDL-Apheresis on inflammation and microcirculation

Apple, 2005, Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome, Clin Chem, 51, 810, 10.1373/clinchem.2004.046292 Bohl, 2009, Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress/rest perfusion magnetic resonance imaging, Ther Apher Dial, 13, 129, 10.1111/j.1744-9987.2009.00667.x Bosch, 2001, Improvement of hemorheology by DALI apheresis: acute effects on plasma viscosity and erythrocyte aggregation in hypercholesterolemic patients, Ther Apher Dial, 5, 372, 10.1046/j.1526-0968.2001.00368.x Brunner, 1995, Change in hemorrheological and biochemical parameters following membrane differential filtration, Int J Artif Organs, 18, 794, 10.1177/039139889501801208 Dihazi, 2008, Proteomic adsorption during LDL-apheresis: Proteomic analysis, Nephro Dial Transplant, 23, 2925, 10.1093/ndt/gfn127 Grundy, 2004, Implications of recent trials for the national Cholesterol educations program adult treatment panel III guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E 2003, Kassenärztliche Bundesvereinigung: Mitteilungen: Zum Beschluss des Bundesausschusses der Ärzte und Krankenkassen vom 24. 3. 2003 zu den therapeutischen Apheresen, Deutsches Ärzteblatt, 30, 2035 Khuseyinova, 2006, Biomarkers of outcome from cardiovascular disease, Curr Opin Crit Care, 12, 412, 10.1097/01.ccx.0000244119.16377.75 Kobayashi, 2005, LDL- apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects, J Clin Apher, 20, 239, 10.1002/jca.20033 Kojima, 2001, Low-density lipoprotein apheresis and changes in plasma components, Ther Apher, 5, 232, 10.1046/j.1526-0968.2001.00344.x Koziolek MJ, Hennig U, Zapf A, Bramlage C, Grupp C, Armstrong VW, Strutz F, Mueller GA: Retrospective analysis of long-term Lipidapheresis at a single centre. Ther Apher Dial, 2009, in press Krieter, 2005, Contact activation in low-density lipoprotein apheresis systems, Artif Organs, 29, 47, 10.1111/j.1525-1594.2004.29007.x Matschke, 2004, Effect of LDL apheresis on oxygen tension in skeletal muscle in patients with cardiac allograft vasculopathy and severe lipid disorder, Clin Hemorheol Microcirc, 30, 263 Mellwig, 2006, Improved Coronary Vasodilatatory Capacity byH.E.L.P. Apheresis: Comparing Initial and Chronic Treatment, Ther Apher Dial, 10, 510, 10.1111/j.1744-9987.2006.00441.x Moriarty, 2004, Effect of low- density lipoprotein cholesterol apheresis on blood viscosity, Am J Cardiol, 93, 1044, 10.1016/j.amjcard.2003.12.059 Moriarty, 2001, C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis, Atherosclerosis, 158, 495, 10.1016/S0021-9150(01)00633-5 Nishimura, 1999, Effects of intensive lipid lowering by low- density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan low-density lipoprotein apheresis prospective study (L-CAPS), Atherosclerosis, 144, 409, 10.1016/S0021-9150(98)00328-1 Otto, 2002, Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease, Ther Apher, 6, 130, 10.1046/j.1526-0968.2002.00366.x Patschan, 2009, Lipid apheresis rapidly increases peripheral endothelial progenitor cell proliferation, J Clin Apher, 24, 180, 10.1002/jca.20208 Sakurai M, Muso E, Matushima H, Ono T, Sasayama S: Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome. Kidney Int Suppl., 1999, 71 Schettler, 2002, First Steps toward the establishment of a German low-density lipoproteinapheresis registry: recommendations for the indication and for the quality management, Ther Apher, 6, 381, 10.1046/j.1526-0968.2002.00426.x Stokes, 2002, Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide, Free Radic Biol Med, 33, 1026, 10.1016/S0891-5849(02)01015-8 Thompson, 2003, LDL Apheresis, Atherosclerosis, 167, 1, 10.1016/S0021-9150(02)00251-4 Tsuchida, 2006, Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS), Int Angiol, 25, 287 Utsumi, 2007, Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis, Clin Chim Acta, 377, 198, 10.1016/j.cca.2006.09.026 Wang, 2004, Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins–reduction of circulating proinflammatory and procoagulatory markers, Atherosclerosis, 175, 145, 10.1016/j.atherosclerosis.2004.03.011 Whayne, 2002, State of the art treatment of the most difficult low density lipoprotein (LDL) cholesterol problems: LDL apheresis, J Ky Med Assoc, 100, 535 Wieland, 2002, Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis, Atherosclerosis, 162, 187, 10.1016/S0021-9150(01)00698-0